Circular MTHFD2L RNA-encoded CM-248aa inhibits gastric cancer progression by targeting the SET-PP2A interaction

Sung, 2021, Global cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA. Cancer J. Clin., 71, 209, 10.3322/caac.21660 Smyth, 2020, Gastric cancer, Lancet, 396, 635, 10.1016/S0140-6736(20)31288-5 Tan, 2015, Genetics and molecular pathogenesis of gastric adenocarcinoma, Gastroenterology, 149, 1153, 10.1053/j.gastro.2015.05.059 Van Cutsem, 2015, HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer, Gastric Cancer, 18, 476, 10.1007/s10120-014-0402-y Song, 2019, AKT as a therapeutic target for cancer, Cancer Res., 79, 1019, 10.1158/0008-5472.CAN-18-2738 2014, Comprehensive molecular characterization of gastric adenocarcinoma, Nature, 513, 202, 10.1038/nature13480 Perrotti, 2013, Protein phosphatase 2A: a target for anticancer therapy, Lancet Oncol., 14, e229, 10.1016/S1470-2045(12)70558-2 Liu, 2019, Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression, EBioMedicine, 40, 263, 10.1016/j.ebiom.2018.12.032 Arnaud, 2011, Mechanism of inhibition of PP2A activity and abnormal hyperphosphorylation of tau by I2(PP2A)/SET, FEBS Lett., 585, 2653, 10.1016/j.febslet.2011.07.020 Kauko, 2020, Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1, J. Biol. Chem., 295, 4194, 10.1074/jbc.RA119.011265 Yuan, 2017, Overexpression of SET oncoprotein is associated with tumor progression and poor prognosis in human gastric cancer, Oncol. Rep., 38, 1733, 10.3892/or.2017.5788 Li, 2008, CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells, Clin. Cancer Res., 14, 3722, 10.1158/1078-0432.CCR-07-4137 Li, 2014, Genetic amplification of PPME1 in gastric and lung cancer and its potential as a novel therapeutic target, Cancer Biol. Ther., 15, 128, 10.4161/cbt.27146 Dacol, 2021, The interaction of SET and protein phosphatase 2A as target for cancer therapy, Biochim. Biophys. Acta Rev. Cancer, 1876, 10.1016/j.bbcan.2021.188578 Liu, 2022, Circular RNAs: characterization, cellular roles, and applications, Cell, 185, 2016, 10.1016/j.cell.2022.04.021 Lei, 2020, Translation and functional roles of circular RNAs in human cancer, Mol. Cancer, 19, 30, 10.1186/s12943-020-1135-7 Jiang, 2021, A novel protein encoded by circMAPK1 inhibits progression of gastric cancer by suppressing activation of MAPK signaling, Mol. Cancer, 20, 66, 10.1186/s12943-021-01358-y Gao, 2021, Circular RNA-encoded oncogenic E-cadherin variant promotes glioblastoma tumorigenicity through activation of EGFR-STAT3 signalling, Nat. Cell Biol., 23, 278, 10.1038/s41556-021-00639-4 Li, 2022, circ-EIF6 encodes EIF6-224aa to promote TNBC progression via stabilizing MYH9 and activating the Wnt/beta-catenin pathway, Mol. Ther., 30, 415, 10.1016/j.ymthe.2021.08.026 Wang, 2021, A novel protein encoded by circASK1 ameliorates gefitinib resistance in lung adenocarcinoma by competitively activating ASK1-dependent apoptosis, Cancer Lett., 520, 321, 10.1016/j.canlet.2021.08.007 Liang, 2021, A novel NF-kappaB regulator encoded by circPLCE1 inhibits colorectal carcinoma progression by promoting RPS3 ubiquitin-dependent degradation, Mol. Cancer, 20, 103, 10.1186/s12943-021-01404-9 Duan, 2022, A novel peptide encoded by N6-methyladenosine modified circMAP3K4 prevents apoptosis in hepatocellular carcinoma, Mol. Cancer, 21, 93, 10.1186/s12943-022-01537-5 Glažar, 2014, circBase: a database for circular RNAs, RNA, 20, 1666, 10.1261/rna.043687.113 Chen, 2016, circRNADb: a comprehensive database for human circular RNAs with protein-coding annotations, Sci. Rep., 6 Liu, 2019, Circbank: a comprehensive database for circRNA with standard nomenclature, RNA Biol., 16, 899, 10.1080/15476286.2019.1600395 Huang, 2021, TransCirc: an interactive database for translatable circular RNAs based on multi-omics evidence, Nucleic Acids Res., 49, D236, 10.1093/nar/gkaa823 Christensen, 2011, Apolipoprotein E and peptide mimetics modulate inflammation by binding the SET protein and activating protein phosphatase 2A, J. Immunol., 186, 2535, 10.4049/jimmunol.1002847 Kristensen, 2019, The biogenesis, biology and characterization of circular RNAs, Nat. Rev. Genet., 20, 675, 10.1038/s41576-019-0158-7 Legnini, 2017, Circ-ZNF609 is a circular RNA that can Be translated and functions in myogenesis, Mol. Cell, 66, 22, 10.1016/j.molcel.2017.02.017 Pamudurti, 2017, Translation of CircRNAs, Mol. Cell, 66, 9, 10.1016/j.molcel.2017.02.021 Yang, 2018, Novel role of FBXW7 circular RNA in repressing glioma tumorigenesis, J. Natl. Cancer Inst., 110, 304, 10.1093/jnci/djx166 Zhang, 2018, A peptide encoded by circular form of LINC-PINT suppresses oncogenic transcriptional elongation in glioblastoma, Nat. Commun., 9, 4475, 10.1038/s41467-018-06862-2 Zhang, 2018, A novel protein encoded by the circular form of the SHPRH gene suppresses glioma tumorigenesis, Oncogene, 37, 1805, 10.1038/s41388-017-0019-9 Yang, 2017, Extensive translation of circular RNAs driven by N(6)-methyladenosine, Cell Res., 27, 626, 10.1038/cr.2017.31 Peng, 2021, A novel protein AXIN1-295aa encoded by circAXIN1 activates the Wnt/beta-catenin signaling pathway to promote gastric cancer progression, Mol. Cancer, 20, 158, 10.1186/s12943-021-01457-w Zhang, 2021, CircDIDO1 inhibits gastric cancer progression by encoding a novel DIDO1-529aa protein and regulating PRDX2 protein stability, Mol. Cancer, 20, 101, 10.1186/s12943-021-01390-y Switzer, 2011, Targeting SET/I(2)PP2A oncoprotein functions as a multi-pathway strategy for cancer therapy, Oncogene, 30, 2504, 10.1038/onc.2010.622 Agarwal, 2014, Antagonism of SET using OP449 enhances the efficacy of tyrosine kinase inhibitors and overcomes drug resistance in myeloid leukemia, Clin. Cancer Res., 20, 2092, 10.1158/1078-0432.CCR-13-2575 Cohen, 2010, Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis, N. Engl. J. Med., 362, 402, 10.1056/NEJMoa0907839 Seo, 2019, Loss of HER2 positivity after anti-HER2 chemotherapy in HER2-positive gastric cancer patients: results of the GASTric cancer HER2 reassessment study 3 (GASTHER3), Gastric Cancer, 22, 527, 10.1007/s10120-018-0891-1